Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

NeOnc Technologies Clinical Expansion Fund

Status
Active
Global HQ
Calabasas, United States
Countries of investment
  • United States
Investment stages
  • Series B
  • Series C
Industries
  • Oncology Biotech
About
NeOnc is a biotech-focused fund enabling novel cancer innovations. It supports clinical advancement toward regulatory milestones and commercialization.
Min check size
$5M
Max check size
$15M
Fund size
NPS

Investment Thesis

Invests in oncology diagnostic and therapeutic startups at the clinical expansion stage.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Amir Heshmatpour (Executive Chairman & President), Thomas Chen (CEO & CSO), Jimmy Delshad (Board Director), Dr. David Peereboom (Scientific Advisory Board)

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp